Pfizer Stock Soars Following Impressive Q2 Earnings Report
Pfizer's Q2 results exceed expectations, driving share price surge and outpacing earnings and revenue estimates.
Pharmaceuticals
Trump’s Tariff Takedown: Proposed 250% Levy on Imported Pharmaceuticals Sparks Global Concern
The US President's latest proposal to impose a 250% tariff on imported pharmaceuticals has sent…
Pfizer Stock Soars: Why Investors Should Consider Buying at $24
Pfizer's stock has been gaining momentum, and investors are advised to consider buying at $24,…
Revolutionizing Healthcare: RPharmy Unveils Innovative Hazardous Drug Risk Initiative
RPharmy to showcase groundbreaking healthcare systems and hazardous drug risk initiative at Florida Society of…
Pfizer Sees Significant Profit Boost from COVID-19 Products and Reduced Expenses
Pfizer's profits have increased due to the success of its COVID-19 products and lower operational…
US Court Strikes Down FDA’s Indication-Specific View of Orphan Exclusivity in Neurelis v Brenner
A US court has ruled against the FDA's indication-specific approach to orphan exclusivity, sparking debate…
Pfizer’s Q2 Results Reveal Significant Sales Growth, Boosts Profit Forecast for 2025
Pfizer's Q2 sales jump to $14.65 billion, driven by strong demand for its pharmaceutical products,…
Pfizer’s Financial Results Exceed Wall Street Expectations, Boosting Investor Confidence
Pfizer's latest financial results have surpassed Wall Street expectations, driven by strong sales of its…
Revolutionizing Healthcare: Rpharmy Unveils Groundbreaking Hazardous Drug Risk Initiative
Rpharmy to showcase innovative hazardous drug risk initiative at Florida Society of Health System Pharmacists…
Nefecon R Receives NMPA Approval for Production Expansion, Revolutionizing Treatment Options
Nefecon R, a groundbreaking medication, has received approval from the NMPA for production expansion, marking…